| 49.31 Data as of May 17 |  +0.05 / +0.10%Today’s Change | 30.00 Today|||52-Week Range 49.85 | +36.78% Year-to-Date |
| Previous close | 49.26 |
| Today’s open | 49.41 |
| Day’s range | 49.18 - 49.78 |
| Volume | 4,326 |
| Average volume (3 months) | 5,204 |
| Market cap | $183.6M |
| Dividend yield | 1.99% |
| Earnings growth (last year) | +34.98% |
| Earnings growth (this year) | -1.09% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +9.75% |
| P/E ratio | 18.1 |
| Price/Sales | 3.19 |
| Price/Book | 3.58 |
| Today’s change | Today’s % change | |
|---|---|---|
| ROCMRochester Medical Co... | +0.22 | +1.51% |
| ATRCAtriCure Inc | -0.18 | -1.95% |
| CYTXCytori Therapeutics ... | -0.02 | -0.75% |
| SLTMSolta Medical Inc | -0.02 | -1.17% |
| Next reporting date | July 25, 2013 |
| EPS forecast (this quarter) | $0.62 |
| Annual revenue (last year) | $41.6M |
| Annual profit (last year) | $10.2M |
| Net profit margin | 24.47% |
Sector Health Technology |
Industry Medical Specialties |
Chairman, President, CEO & Secretary Kevin L. Cornwell, MBA |
Chief Financial Officer, Treasurer, Director & CAO Paul O. Richins, MBA |
Corporate headquarters Midvale, Utah |
.
